We have recently obtained 18 distinct cDNA clones representing different genes expressed in the early phase of EBV infection. One of them, c37, which is situated at the position 12907-122451 in the B95-8 viral genome, is shown here to code for a viral desoxyribonuclease [DNase]. Cell free translation of c37-selected messenger RNA yielded a protein of about 52 KDa which was immunoprecipitated by a high EA titer serum from nasopharyngeal carcinoma patient. This protein showed a DNase activity which was resistant to high salt concentrations (150 to 300mM KCI) and was specifically neutralized by EA positive serum. These properties are typical of the EBV-specific DNase activity that we recently described in chemically induced EBV-transformed lymphoid cells. The same results were obtained on cell-free translation of the native RNA synthesized in vitro from pGEM-37 plasmid containing the entire c37 cDNA sequence (1.53 Kb). These data indicate that the BGLF5 open reading frame contained in c37 encodes for the EBV-specific DNase.
INTRODUCTION
Epstein-Barr virus (EBV), an ubiquitous human herpesvirus, causative agent of infectious mononucleosis has been implicated in two human cancers : Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC). Additionally, EBV is capable of immortalizing primate or human B lymphocytes into continuously proliferating cell lines carrying the EBV genome (1, 2, 3) .
Although the expression of the viral genome is repressed and limited to a latent state in most infected cells, a productive viral cycle can be induced in some cell lines. In a substantial fraction of latently infected cells, treatment by 12-O-tetradecanoylphorbol-13-acetate (TPA) (4) and by sodium butyrate (SB) (5) leads to virus replication, as characterized by the successive appearance of early antigen (EA) in the early stage, viral capsid antigen (VCA) at the late stage, and finally, production of viral particles.
A viral DNase activity has been detected during the early stage both in reactivated and EBV-positive lymphoid cell lines (6, 7, 8) . The viral enzyme activity may be neutralized by early antigen positive sera from NPC patients (7, 8, 9) and the degree of anti-DNase activity correlates with EA antibody titers (8) , indicating that viral DNase is one of the constituants of the EA complex. Significantly elevated, anti-DNase antibody titers in NPC patients might imply reactivation of the viral genome and so their titre could be valuable as a prognostic element. Viral DNase appears to be essential for DNA synthesis, repair, recombination and virus replication (9, 10) . Biochemical studies of a DNase from HSV showed that this enzyme has endonuclease activity and both 5' and 3' exonuclease activities (11, 12 ) though its precise role in viral infection is not yet clear. We therefore attempted the identification and characterization of the EBV-specific DNase gene as a first step for determining its role in EBV infection and replication in vivo. The entire EBV genome has recently been sequenced (13) , however, the DNase gene has not been precisely located, although a weak amino acid sequence homology between the HSV exonuclease gene and an EBV Bam HI B/G fragment has recently been described by Me Geoch et al. (14) . We have attempted to localize and characterize some early EBV genes using a library of complementary DNA to mRNAs from P3HR-1 cells expressing only early viral functions (15) .
The present report concerns one cDNA clone which allowed us to localize a typical viral DNase on the Bam HI B and G fragments of EBV genome. This finding should facilitate further characterization of the enzyme and the understanding of its role in EBV infection.
MATERIALS AND METHODS
(a) Lymphoid cell culture and EBV induction with TPA plus SB The EBV-producer P3HR-1 line was propagated by seeding 5x10 5 cells per ml in RPMI 1640 medium supplemented with 10 % heat-inactived foetal calf serum, 100 U of penicillin per ml, and 250^ig of streptomycin per ml, and grown at 37° C. The viral cycle in P3HR-1 cells was induced by adding 20 ng of TPA per ml and 2mM SB (8) . Simultaneously cells were treated with 50^ig of araT (arabinofuranosylthymine) or 200mM PAA (phosphonoacetic acid) to limit the viral cycle to the early stage only (17) . Cells were harvested 3 days later and total cytoplasmic RNAs were extracted.
The percentage of EA-positive cells was evaluated on smears using the indirect immunofluorescence test (18) .
(b) RNA extraction and RNA blot Cytoplasmic RNA was prepared by the Guanidinium/cesium chloride method (19) . hours, the RNA pellet was resuspended in 7M guanidine hydrochloride and precipitated by adding 1M acetic acid and ethanol.
mRNA was selected by passing total cytoplasmic RNA for 4 times through an oligo-dT-cellulose column.
Northern blot hybridization was done as described previously (15) , except that genescreen sheets (NEN) were used instead of nitrocellulose. protein fractions were analyzed on NaDodSO./polyacrylamide gels as described by
Laemmli (21) (e) DNase activity assays EBV-specific DNase activity was measured as described previously (8) . Briefly a final assay volume consisted of 27.5u.l of the tranlation mixture described above, a final concentration of 3mM MgCl_, lOng DNA corresponding to 27000 cpm (2.7x10 cpm/jig DNA nick-translated with ' 2 P-dCTP), 1mM dithiothreitol and 50mM TRI5- The quantity and purity of the synthesized RNA were determined by electrophoresis on RNA gel (15) and checked by UV transillumination. With 10ojg of pGEM-37 we obtained about 6(ig of pure 1.5 kb RNA from both promoters.
(g) DNA sequence analysis
The sequences of both extremities of c37 were analyzed using both GEMSEQ dsDNA sequencing (Promega, Biotec) and the method of Maxam and Gilbert (22) . For the GEMSEQ sequencing system, pGEM-37 was linearized by digestion with EcoRl or Hind III enzymes and then annealed respectively with SP 6 or T7 primer at 100° C for 3 min. in 10mM Tris-HCl (pH : 7.5) and 5mM NaCl. ?2 P-dATP was added to the above mixture and then pGEM-37 sequence was analyzed by dideoxynucleotide chain termination sequence method (Promega, Biotec). The sequence was also confirmed in part by the method of Maxam and Gilbert.
RESULTS (a) Hybrid selection of the DNase encoding clone
The different cDNA clones derived from mRNAs of P3HR-1 cells expressing early EBV antigens were used to select mRNAs from induced P3HR-1 cells. The selected mRNAs were translated in a reticulocyte lysate system, and the peptides were tested for their ability to degrade P-labelled DNA. One clone, c37, selected a mRNA which translated to a typical EBV DNase which digested labelled DNA efficiently at 150 mM KCL and was inhibited by antiserum to EA but not by EA", VCA + serum (Fig. 1B) . By contrast, reticulocyte DNase was almost totally inhibited by 150 mM KCI, but was unaffected by either EA" or EA + sere (Fig. 1A) .
Polyacrilamide gel electrophoresis of the cell-free translation products shows several bands, one of which, 52 Kd, is specifically precipitated by high titre anti-EA serum (Fig. 2, bands A,a) . To investigate whether the c37 cDNA sequence contained a complete DNase gene, we cleaved it with Pst-1 and inserted it into the pGEM' -1 plasmid. Two kinds of capped native RNA (about 1.5 kb) were synthesized in vitro, one from the T7 promoter, which has the same direction as the left strand of EBV genome, and the other from the SP6 promoter which has the opposite direction ( Figure 3D ). These RNAa were translated in vitro and we tested the produced protein for DNase activity. The protein translated from the RNA origination from the T7 promotor digested labelled DNA in presence of 150 mM KC1 and WBB specifically inhibited by anti-EA serum identically to the translation product from the hybrid selected P3HR-1 mRNA (Fig. 1C) . The RNA produced from the SP6 promotor produced no DNase activity on translation (Fig. 1C-open squares) . PAGE shows that the translated product from the T7 promotor RNA corresponds to a polypeptide of 52 Kda which is precipitated by anti-EA serum (Fig. 2, lanes B,b) whereas the SP6 promotor RNA gives no prscipitable product (Fig. 2, lanes C,c) . The band at ca 50 Kda which residues at position 120907, a probable initiator ATG at 122341 and had its 5' terminus at 122451 (Figure 3Bc ). For 100 bp from the 3' end its sequence was identical to that of B95-8 in that region, but at the 5' end some differences existed. Our 5' end sequence extends to the region of the B95-8 Bam HI site where it shows 2 nucleotide changes : Adenine, instead of Guanine at 122315 and Thymine instead of Cytosine at 122318, explaining the absence of Bam HI cleavage of P3HR-1 strain in this region (24) . The size of our cDNA about 1.53 kb as determined on agarose gel electrophoresis was identical to that calculated from the corresponding B95-8 genomic sequence. This suggests that no major splicing occurs on transcription of this reading frame.
Northern blotting of mRNA from P3HR-1 cells limited to early viral expression with c37 clone as probe revealed 2 transcripts : one major at 1.8 kb and a minor 3.8 kb component. Virus-producing P3HR-1 cells contained RNAs of 0.8 ; 1.8 and 3.8 kb reactive with the c37 probe (Figure 4) . The 0.8 kb RNA was detected only in productive cells and is a late messenger. The major early 1.8 kb RNA corresponds to c37 cDNA open reading frame (ORF) and thus might be the DNase messenger. The 3.8 Kb RNA which is transcribed weakly during early stage but more strongly during the productive cycle is too large to be encoded by the c37 ORF. In order to determine the origin of the 3.8 Kb RNA, we examined an adjacent 1.2 Kb sequence situated upstream to the c37 ORF, corresponding to a Pstl-Bgl II fragment of the B95-8 genome ( Figure 3C ). Using this sequence as a probe, a single major 3.8 Kb RNA was found in PA A-treated P3HR-1 cells, while two major RNAs : 3.8 Kb and 2.2 Kb were identified in productive cells. An additional very weak 3.5 Kb RNA was detected by both probes in both early and late viral stages in P3HR-1 cells. The Pstl-Bgl II fragment also revealed a weak and indistinct band in the 1.8 kb region (Figure 4b2 From the sequence analysis of both end of c37 cDNA, which allowed us to situate the AATAAA and ATG signals, we would predict that the DNase-coding cDNA sequence corresponds to the open reading frame BGLF5 of B95-8 genome described by Seguin et el. (23) . The cDNA clone possessed an additional 110 bp upstream of the presumptive initiator ATG in which no TATA box-like sequence was identified (25) , agreeing with previous reports (23) . As expected from the origin of c37 clone (P3HR-1 strain), its sequence had no Bam HI cleavage site (24) and our sequence data on the corresponding region of our cDNA clone show two nucleotide changes in the B95-8 Bam HI site (23) . These minor alterations in the c37 sequence did not affect the enzyme activity since they did not change the amino-acid sequence of BGLF5 ORF.
During the early stage of the EBV cycle, at least 2 polyadenylated cytoplasmic RNAs have been identified from c37 region. An abundant 1.8 kb transcript corresponds in size to the BGLF5 ORF ( Figure 3A) . Our data also imply that the BGLF4 ORF, situated upstream of BGLF5 may encode a late 2.2 Kb RNA since a probe from this region revealed no early RNA of the size of BGLF4 ORF, but a 2.2
Kb RNA was present in late-antigen-expressing P3HR-1 cells. The 0.8 kb RNA might be derived from BBLF1 which has been reported to encode a late RNA (13) . Both We cannot however exclude the possibility that the 52 KDa polypeptide is only a part of the DNase molecule and that other molecules are required for its function as the virus specific enzyme. Specific antibody against this protein is required for more detailed studies. As expected from the previous data (7, 8) , the DNases translated in vitro from either c37 hybrid-selected RNA or nRNA of pGEMI system were precipitated by EA positive serum from NPC patients, and their activities were completely neutralized in the presence of the serum, confirming that viral DNase is an element of the EA complex.
Our data indicate that the 1.53 kb c37 cDNA sequence encodes an active EBV-specific DNase with the expected biochemical and immunological properties.
These findings may permit us to develop more specific tests for the prognosis of NPC, and for the further characterization of this enzyme.
